🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Bipolar disorder is characterized by mood swings that range from from high ...
Status
Completed
Location
Multiple Locations
Start Date
2005-07
Trial ID
NCT00159783
Treatments Being Tested
This is a 12-week study that will test the safety and efficacy of asenapine...
Status
Completed
Location
Multiple Locations
Start Date
2005-06-02
Trial ID
NCT00145470
Schizophrenia is a brain disease. The primary features of schizophrenia are...
Status
Completed
Location
Multiple Locations
Start Date
2005-04
Trial ID
NCT00156091
Treatments Being Tested
Schizophrenia is a brain disease. The primary features of schizophrenia are...
Status
Completed
Location
Multiple Locations
Start Date
2005-09
Trial ID
NCT00156065
Treatments Being Tested
Our proposal is to administer asenapine to patients who are clinically agit...
Status
Completed
Location
St. Joseph's Hospital Health Center-Comprehensive Psychiatric Emergency Program (CPEP)
Start Date
2012-04
Trial ID
NCT01400113
This study is designed to evaluate efficacy and safety of HP-3070 compared ...
Status
Completed
Location
Noven Pharmaceuticals, Inc.
Start Date
2016-08
Trial ID
NCT02876900
Treatment with conventional antipsychotics such as haloperidol has little e...
Status
Completed
Location
Multiple Locations
Start Date
2005-04-21
Trial ID
NCT00212836
Treatments Being Tested
The primary objective of this trial was to characterize the long-term (up t...
Status
Completed
Location
Multiple Locations
Start Date
2005-08
Trial ID
NCT00145509
Schizophrenia is a brain disease. The primary features of schizophrenia are...
Status
Completed
Location
Multiple Locations
Start Date
2005-02-15
Trial ID
NCT00151424
Treatments Being Tested
A multicenter, randomized, parallel-group, double-blind, fixed dose, 6-week...
Status
Completed
Location
Multiple Locations
Start Date
2010-05-25
Trial ID
NCT01098110
Treatments Being Tested